News Highlights: Top Company News of the Day
Shell to Sell Permian Assets to ConocoPhillips for $9.5 Billion
The sale is one of the biggest recent transactions in the shale
patch as large oil companies come under increasing pressure to
diversify beyond fossil fuels.
APA Rivals Brookfield Bid for AusNet
APA Group set a deadline of one week for AusNet Services Ltd. to
allow due diligence access after saying it is willing to trump an
existing takeover proposal made by Brookfield Asset Management.
Honeywell at Odds With Asbestos Trust Over Bankruptcy Deal
Honeywell International is locked in a standoff over asbestos
payments with a bankruptcy trust that has accused the industrial
conglomerate of "bullying and extortionate tactics" to settle
injury liabilities for less than full value.
Shopping Online Is Getting More Expensive
FedEx will raise shipping rates at the fastest pace in nearly a
decade, adding to pressure on retailers to pass costs to
SEC Is Investigating Activision Blizzard Over Workplace Practices, Disclosures
Federal regulators have launched an investigation into
Activision Blizzard, including how the videogame company handled
employees' allegations of sexual misconduct and workplace
GM to Replace Batteries in Recalled Chevy Bolts
Dealerships are scheduled in mid-October to begin fixing
Chevrolet Bolts that were recalled for fire risk, although many
owners of the electric car likely will have to wait months.
Pfizer, BioNTech Say Vaccine Is Safe for Young Children
The companies said the Covid-19 vaccine generated levels of
antibodies that were similar to those of younger adults. Pfizer
will seek emergency use authorization in the U.S. as early as the
end of the month.
Freshworks Shouldn't Spoil on Delivery
The cloud-software company's IPO should stand out for its
reasonable valuation and path to profitability.
Twitter to Pay $809.5 Million to Settle Securities Suit
The consolidated class-action securities lawsuit alleged the
social-media company deliberately misled investors about user
engagement in 2015.
AstraZeneca Breast Cancer Drug Found to Reduce Risk of Dying
The drug maker said Enhertu significantly reduced the risk of
death or disease progression in women with advanced disease in a
large clinical trial, the latest sign that its push into oncology
is starting to pay off.
(END) Dow Jones Newswires
September 21, 2021 03:15 ET (07:15 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.